Dr Karla Murta explores the potential complications in the upper and mid-face, alongside techniques to mitigate these risks.
It is undeniable that upper and mid-face injectable treatments create impressive results in rejuvenation and can be provided to patients with minimal downtime. Botulinum toxin, dermal fillers and collagen stimulants are amongst the common treatments used in the upper and mid-face, and they can provide substantial aesthetic improvement due to reduction of rhytids, volume restoration and improving facial contour.1
However, these procedures are not without risks. The anatomy of these areas is challenging due to the proximity of critical anatomic structures, including numerous blood vessels and nerves. The risks encompass bruising, swelling, infection, asymmetry, vascular occlusion and, in rare cases, blindness.2,3,4
This article aims to provide insight into avoiding complications associated with injectable treatments in the upper and mid-face, and the proper techniques to avoid them occurring.